Metraipolis › archive › dc_72013d3088fe

AS01B-, MF59-, and alum-based adjuvants and HIV vaccine immunogenicity: a post-hoc cross-protocol comparison of results from HVTN 100, 107, 120, and 702 — Europe PMC PMID:41909709

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41909709
DOI
10.3389/fimmu.2026.1768201
License (as archived)
solo-consultazione
Archived
2026-11-04T11:51:14.006Z
SHA-256 of the archived text
a74b05057c2c4941698045a73ffb5366c00ae2d52c21d06b22bcc2c810767ef0
Stable URL of this page
https://metraipolis.com/documento/dc_72013d3088fe

How to cite

AS01B-, MF59-, and alum-based adjuvants and HIV vaccine immunogenicity: a post-hoc cross-protocol comparison of results from HVTN 100, 107, 120, and 702 — Europe PMC PMID:41909709 — Europe PMC (en), https://europepmc.org/article/MED/41909709 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_72013d3088fe (Metraipolis archive dc_72013d3088fe, sha256 a74b05057c2c4941698045a73ffb5366c00ae2d52c21d06b22bcc2c810767ef0)
BibTeX
@misc{dc72013d3088fe,
  title = {AS01B-, MF59-, and alum-based adjuvants and HIV vaccine immunogenicity: a post-hoc cross-protocol comparison of results from HVTN 100, 107, 120, and 702 — Europe PMC PMID:41909709},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41909709},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_72013d3088fe; sha256 a74b05057c2c4941698045a73ffb5366c00ae2d52c21d06b22bcc2c810767ef0},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41909709. Agents can read the archived copy with the MCP tool read_document.